AstraZeneca is stepping further into the obesity field with an option for a fledgling startup that seeks to preserve muscle ...

The digital health company Hims & Hers has started prescribing a cheaper, compounded version of a popular GLP-1 weight loss ...

AstraZeneca said it will continue to be the conduit for sharing Chinese innovation with the rest of the world, but will ...

Plus, news about BioNTech, Medigene, YGION Biomedical, Eli Lilly and Alloy Therapeutics: Lyra lays off 87 employees: The Watertown, MA-based biotech will let go of 75% of its workforce, stop ...

Larimar Therapeutics’ stock $LRMR shot up by as much as 20% after announcing Monday that the FDA had lifted its partial ...

AstraZeneca on Monday morning unveiled its ambitious plan to be one of the fastest growing pharma companies by the end of the ...

Investors continue to flock toward antibody-drug conjugates. Pheon Therapeutics is the latest to catch the tailwinds of the ...

GSK announced Tuesday morning that its experimental antibody treatment reduced the yearly rate of asthma attacks across two ...

LabGenius has secured £35 million ($44.5 million) in a Series B raise to expand its antibody discovery platform and advance a ...

At least seven members of Congress since 2023 have bought and sold stocks of life science companies that would gain from ...

The trade group BIO has parted ways with 30 employees, including several senior leaders, in what sources are describing as a ...

A federal jury in Delaware determined that AstraZeneca infringed two Pfizer patents with its blockbuster cancer treatment ...